prednisolone phosphate has been researched along with B16 Melanoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banciu, M; Licarete, E; Luput, L; Patras, L; Rauca, VF; Sesarman, A | 1 |
| Banciu, M; Drotar, D; Dume, B; Gherman, C; Licarete, E; Luput, L; Patras, L; Porfire, A; Rauca, VF; Sesarman, A; Stejerean, I; Toma, VA | 1 |
| de Wijs-Rot, N; Pieters, EHE; Smits, CJP; Smits, EAW; Soetekouw, JA; Vromans, H | 1 |
| Banciu, M; Metselaar, JM; Schiffelers, RM; Storm, G | 2 |
| Boekhoven, RW; Kluza, E; Nicolay, K; Schiffelers, RM; Schmid, S; Storm, G; Strijkers, GJ; van der Schaft, DW; Yeo, SY | 1 |
| Aime, S; Cittadino, E; Crielaard, BJ; Ferraretto, M; Lammers, T; Maiocchi, A; Storm, G; Terreno, E; Torres, E | 1 |
| Fens, MH; Janssen, AP; Metselaar, JM; Molema, G; Schiffelers, RM; Storm, G | 1 |
| Banciu, M; Fens, MH; Metselaar, JM; Schiffelers, RM; Storm, G | 1 |
| Banciu, M; Fens, MH; Schiffelers, RM; Storm, G | 1 |
10 other study(ies) available for prednisolone phosphate and B16 Melanoma
| Article | Year |
|---|---|
The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Delivery Systems; Humans; Liposomes; Macrophages; Melanoma, Experimental; Mice; Neovascularization, Pathologic; Prednisolone; Tumor Microenvironment | 2019 |
Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment.
Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Doxorubicin; Liposomes; Macrophages; Melanoma, Experimental; Mice; Neovascularization, Pathologic; Oxidative Stress; Prednisolone; Tumor Microenvironment | 2020 |
The availability of drug by liposomal drug delivery : Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate.
Topics: Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Glucocorticoids; Humans; Kinetics; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Polyethylene Glycols; Prednisolone; Tissue Distribution; Tumor Cells, Cultured | 2019 |
Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.
Topics: Animals; Budesonide; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Colonic Neoplasms; Dexamethasone; Dose-Response Relationship, Drug; Drug Delivery Systems; Endothelium, Vascular; Glucocorticoids; Inflammation; Injections, Subcutaneous; Liposomes; Male; Melanoma, Experimental; Methylprednisolone; Mice; Mice, Inbred C57BL; Nanomedicine; Neovascularization, Pathologic; Prednisolone; Receptors, Glucocorticoid; Time Factors; Tumor Burden; Umbilical Veins | 2008 |
Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line, Tumor; Glucocorticoids; Humans; Inflammation; Liposomes; Macrophages; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasms; Prednisolone | 2011 |
MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Contrast Media; Gadolinium; Glucocorticoids; Liposomes; Magnetic Resonance Imaging; Magnetics; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Prednisolone; Tumor Burden | 2012 |
Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.
Topics: Animals; Cell Proliferation; Colonic Neoplasms; Endothelial Cells; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Necrosis; Prednisolone; Tissue Distribution | 2005 |
Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Colonic Neoplasms; Drug Delivery Systems; Endothelium, Vascular; Humans; Injections, Intravenous; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Prednisolone; Time Factors; Umbilical Veins | 2006 |
Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.
Topics: Animals; Antineoplastic Agents; Clodronic Acid; Liposomes; Macrophages; Male; Melanoma, Experimental; Mice; Mice, Nude; Neovascularization, Pathologic; Prednisolone; Skin Neoplasms; Tumor Burden | 2008 |
Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice.
Topics: Animals; Antineoplastic Agents; Budesonide; Dexamethasone; Dose-Response Relationship, Drug; Liposomes; Male; Melanoma, Experimental; Methylprednisolone; Mice; Mice, Inbred C57BL; Organ Size; Prednisolone; Spleen | 2008 |